Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies
暂无分享,去创建一个
Michael Goodman | Olca Basturk | Serdar Balci | Pelin Bagci | O. Basturk | V. Adsay | K. Jang | S. Kong | M. Goodman | N. Ohike | Takuma Tajiri | Kee-Taek Jang | P. Bagci | Gizem Akkaş | Serdar Balci | N. Dursun | B. Saka | Takuma Tajiri | H. Gucer | Volkan Adsay | Michelle D. Reid | Michelle D Reid | Nobuyuki Ohike | Burcu Saka | Ipek Erbarut Seven | Nevra Dursun | Hasan Gucer | So Yeon Kong | Gizem Akkas | I. E. Seven | Nobuyuki Ohike
[1] J. Polak,et al. Endocrine tumors of the pancreas , 1988 .
[2] B. Eriksson,et al. Endocrine tumours of the pancreas. , 2005, Best practice & research. Clinical gastroenterology.
[3] A. Krasinskas,et al. Comparison of methods for proliferative index analysis for grading pancreatic well-differentiated neuroendocrine tumors. , 2012, American journal of clinical pathology.
[4] Laura H. Tang,et al. Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification , 2011, The American journal of surgical pathology.
[5] N. Adsay,et al. Neuroendocrine Tumors of the Pancreas: Current Concepts and Controversies , 2014, Endocrine Pathology.
[6] A. Benson,et al. The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs): Well-Differentiated NETs of the Distal Colon and Rectum , 2010, Pancreas.
[7] Laura H. Tang,et al. Objective Quantification of the Ki67 Proliferative Index in Neuroendocrine Tumors of the Gastroenteropancreatic System: A Comparison of Digital Image Analysis With Manual Methods , 2012, The American journal of surgical pathology.
[8] C. Cohen,et al. Phosphohistone H3 and Ki-67 Labeling Indices in Cytologic Specimens from Well-Differentiated Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas: A Comparative Analysis Using Automated Image Cytometry , 2013, Acta Cytologica.
[9] Toby C. Cornish,et al. Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic Rate , 2013, The American journal of surgical pathology.
[10] Manal M. Hassan,et al. The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Well-Differentiated Neuroendocrine Tumors of the Jejunum, Ileum, Appendix, and Cecum , 2010, Pancreas.
[11] B. Weinhold. Epigenetics: The Science of Change , 2006, Virchows Archiv.
[12] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[13] D. Allison,et al. Endocrine tumors of the pancreas. , 1989, Radiologic clinics of North America.
[14] R. Jensen,et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. , 2010, Pancreas.
[15] M. Salto‐Tellez,et al. Computer‐assisted pathological immunohistochemistry scoring is more time‐effective than conventional scoring, but provides no analytical advantage , 2010, Histopathology.
[16] D. Klimstra. Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging. , 2013, Seminars in oncology.
[17] G. Baron,et al. Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors , 2009, Modern Pathology.
[18] P. Schnabel,et al. Grading neuroendokriner Tumoren , 2016, Der Pathologe.
[19] V. Adsay. Ki67 Labeling Index in Neuroendocrine Tumors of the Gastrointestinal and Pancreatobiliary Tract: To Count or Not to Count Is Not the Question, But Rather How to Count , 2012, The American journal of surgical pathology.
[20] M. Washington,et al. Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set , 2010, The American journal of surgical pathology.
[21] K. Hess,et al. Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] C. Compton,et al. Exocrine and Endocrine Pancreas , 2012 .
[23] A. Scarpa,et al. Pathology and Genetics , 2010 .